The Defense Strategies Institute presents the 2nd annual Government Biotechnology Innovation Summit, to be held at 151 St. George, National Harbor in Maryland on Sept. 4-5.

This summit will facilitate dialogue between biotech experts and government officials to address emerging challenges and ensure that regulatory frameworks keep pace with technological advancements.

This forum will cover the profound implications of biotech advancements on national security and governance. Biotechnology has rapidly evolved, presenting both promising opportunities and potential threats. For example, developments in genetic engineering enable the creation of novel pathogens used in bioterrorism. The development of rapid diagnostic tools and vaccines against infectious diseases is essential for preempting potential pandemics.

Furthermore, biotech innovations enhance agricultural safety by improving crop resilience against pests, diseases, and environmental stressors, ensuring food security.

Topics to be discussed at the summit include: 

• U.S. Biotechnology Policy and Innovation: Spearheading DoD Biomanufacturing Strategy Development
• Enhancing Real-World Outcomes Through Biotech Research Initiatives at ARPA-H
• Strategies for Mitigating Bioterrorism Threats to Public and Agricultural Health
• Driving AFRL’s Warfighter Capabilities through Biotech Innovations
• Biotechnological Innovations in Support of the Warfighter: Enhancing Performance and Resilience
• Fostering Integrated, Cross-Disciplinary Approaches to Preparedness for an Expanded Bioeconomy
• Supporting the SOF Community and an Expanded Focus on Optimized Performance

For further information about this event and the full agenda, visit the event website.

If you have questions, please contact the Defense Strategies Institute.